QUREuniQure N.V.
Chart data are delayed by 15 minutes.
Main metrics
Providers
All 1 issuers →
Backed FinanceQUREx$96.21K100.0%Chains
All 10 chains →
Solana$78.07K81.1%
TON$18.12K18.8%
XLayer$18.770.0%
Arbitrum One—0.0%
BNB Chain—0.0%All 10 chains →About QURE
uniQure N.V. is a biopharmaceutical company focused on gene therapy for patients with severe genetic and other serious diseases. Its current portfolio includes HEMGENIX for hemophilia B and a pipeline of investigational therapies aimed at disorders such as Huntington’s disease, epilepsy, ALS, and Fabry disease. The company uses an adeno-associated virus (AAV) platform to develop one-time treatments designed to address the underlying cause of disease, with activities spanning research, development, manufacturing, and commercialization. Headquartered in Amsterdam, the Netherlands, uniQure serves the rare-disease and specialty therapeutic markets through both proprietary programs and selected partnerships.
Valuation
Profitability
Balance sheet
Trading
| Issuer | Token | Chains | Dividend | Shares | Value | Share |
|---|---|---|---|---|---|---|
| Backed Finance | QURExuniQure xStock | | 2.2K | $96.21K | 100.0% |
| Chain | Issuers | Shares | Value | Share |
|---|---|---|---|---|
| Solana | | 1.8K | $78.07K | 81.1% |
| TON | | 407.1 | $18.12K | 18.8% |
| XLayer | | 0.4 | $18.77 | 0.0% |
| Arbitrum One | | 0 | — | 0.0% |
| BNB Chain | | 0 | — | 0.0% |
 Ethereum | | 0 | — | 0.0% |
 HyperEVM | | 0 | — | 0.0% |
 Ink | | 0 | — | 0.0% |
 Mantle | | 0 | — | 0.0% |
 Optimism | | 0 | — | 0.0% |
No dividend has been recorded for this asset.
No corporate event has been recorded for this asset.
